TNF and neoplasm: As expected, the proportion of matured and activated DC cells in tumor cells of mice treated with SN38-NPs or SN38-URNPs was increased significantly, and this was accompanied by elevated levels of IFN-γ, IL-6, and TNF-α in the serum.